Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Cardiac Biomarkers Testing Market Size, Value And Growth Trajectory Through 2030
The cardiac biomarkers testing market has experienced rapid expansion over recent years. Its valuation is projected to increase from $14.95 billion in 2025 to $16.7 billion by 2026, reflecting a compound annual growth rate (CAGR) of 11.7%. This market’s past growth is attributable to factors such as a rise in cardiovascular disease cases, greater public understanding of heart health, innovations in laboratory diagnostics, expanding hospital infrastructure, and a surge in government-led healthcare programs.
The cardiac biomarkers testing market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $25.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. This anticipated growth during the forecast period is primarily driven by factors such as the integration of AI in diagnostics, the increasing prevalence of home-based and remote monitoring solutions, advancements in precision medicine, the creation of multi-biomarker panels, and a heightened need for real-time cardiac monitoring. Key trends expected during the same period encompass the wider adoption of point-of-care testing, the emergence of miniaturized and portable diagnostic devices, advancements in biomarker multiplexing technologies, the development of personalized cardiac risk profiling, and the incorporation of wearables for cardiac monitoring.
Get A Free Sample Report With In-Depth Market Insights:
Cardiac Biomarkers Testing Market Growth Catalysts And Demand Drivers
The increasing occurrence of cardiovascular diseases is projected to drive the growth of the cardiac biomarkers testing market moving forward. Cardiovascular disease refers to a range of conditions affecting the heart or its blood vessels. Cardiac biomarker tests assist in measuring biomarker levels to quickly ascertain the severity and extent of a heart attack. Therefore, a higher prevalence of cardiovascular diseases will lead to increased demand for cardiac biomarker testing solutions. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, stated that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, which is up 4.0% from 224.4 per 100,000 in 2023. Consequently, the rising prevalence of cardiovascular diseases is fueling the expansion of the cardiac biomarkers testing market.
Cardiac Biomarkers Testing Market Segmentation And Category Overview
The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Cardiac Biomarkers Testing Market Trends Shaping Long-Term Demand
Leading companies in the cardiac biomarker testing market are forming strategic alliances to deliver technology aimed at identifying early indications of heart conditions and enhancing patient results. These collaborations within cardiac biomarker testing promote cooperation among firms, enabling the development of innovative diagnostic tools, expanding their market presence, and accelerating the availability of advanced testing solutions for improved cardiovascular care. For instance, in September 2024, MediBuddy, an Indian-based healthcare technology company that offers a comprehensive platform for telehealth services, health management, and insurance assistance, joined forces with Philips, a Netherlands-based conglomerate corporation. Through this partnership, they intend to improve cardiac care in India by integrating Philips’ HeartPrint technology, which allows for regular monitoring and risk assessment of heart health. This innovative strategy provides users with sophisticated tools on the MediBuddy platform, encouraging active management of heart health and leading to better outcomes.
Cardiac Biomarkers Testing Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the cardiac biomarkers testing market are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation
View The Full Cardiac Biomarkers Testing Market Report:
Cardiac Biomarkers Testing Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the cardiac biomarkers testing market in 2025. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
